Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is determine the safety, efficacy and tolerability of a novel drug
APH-1501 as a pharmacotherapy for Opioid Dependence. The investigators will evaluate the
safety of escalating doses APH-1501.